FluoretiQ expands its arsenal to fight antimicrobial resistance

Our member and University of Bristol spin-out FluoretiQ, the award-winning medical devices company, has announced a new initiative in its fight against antimicrobial resistance (AMR). According to a recent Lancet report, AMR isn’t a pandemic in waiting, its already here. AMR infections are estimated to cause 700,000 deaths each year globally. That figure is predicted to…

Read More